0001831283-23-000054.txt : 20230331 0001831283-23-000054.hdr.sgml : 20230331 20230331162139 ACCESSION NUMBER: 0001831283-23-000054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230329 FILED AS OF DATE: 20230331 DATE AS OF CHANGE: 20230331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jahn Brianne CENTRAL INDEX KEY: 0001885012 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40947 FILM NUMBER: 23788068 MAIL ADDRESS: STREET 1: C/O LIANBIO STREET 2: 103 CARNEGIE CENTER DRIVE, SUITE 215 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LianBio CENTRAL INDEX KEY: 0001831283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 486-2308 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 wf-form4_168029408142979.xml FORM 4 X0407 4 2023-03-29 0 0001831283 LianBio LIAN 0001885012 Jahn Brianne C/O LIANBIO 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 0 1 0 0 Chief Business Officer 0 Ordinary Shares 2023-03-29 4 A 0 224005 0 A 224005 D Represents restricted share units granted to the Reporting Person under the LianBio 2021 Equity Incentive Plan. Each restricted share unit represents the contingent right to receive one share of the Issuer's Ordinary Shares. 25% of the restricted share units shall vest on March 29, 2024; the remainder shall vest in 25% annual installments such that the restricted share units are fully vested on March 29, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date. By: /s/ Angela Chen, Attorney-in-Fact 2023-03-31